Loring Wolcott & Coolidge Fiduciary Advisors’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-700
Closed -$23K 638
2020
Q4
$23K Hold
700
﹤0.01% 496
2020
Q3
$15K Hold
700
﹤0.01% 491
2020
Q2
$14K Hold
700
﹤0.01% 481
2020
Q1
$12K Hold
700
﹤0.01% 527
2019
Q4
$27K Hold
700
﹤0.01% 501
2019
Q3
$25K Buy
+700
New +$25.1K ﹤0.01% 497
2017
Q4
Sell
-11
Closed -$1K 861
2017
Q3
$1K Buy
+11
New +$477 ﹤0.01% 740

Other funds holding SNV

Loring Wolcott & Coolidge Fiduciary Advisors's SNV Position: Q1 2021 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Synovus (SNV) in Q1 2021, closing a stake of 700 shares — an estimated $23K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in SNV in Q3 2017 and held it in 7 quarters. The position peaked at $27K in Q4 2019. 382 funds tracked by Wall St. Rank hold SNV as of Q1 2021.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Synovus position as of Q1 2021 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 700 Synovus shares in Q1 2021, an estimated $23K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Synovus in Q3 2017 and held it in 7 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Synovus position peaked at $27K in Q4 2019.
  • 382 funds tracked by Wall St. Rank held Synovus as of Q1 2021.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2021, filed 14 Apr 2021.